Sutro Biopharma
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $63,745 | $17,399 | $14,809 | $8,520 |
Gross Profit | 61,845 | 17,399 | 12,941 | 8,520 |
EBITDA | -3,345 | -63,425 | -59,530 | -39,078 |
EBIT | -5,245 | -65,325 | -61,398 | -40,877 |
Net Income | -11,499 | -75,968 | -72,443 | -48,787 |
Net Change In Cash | 63,745 | 17,399 | 14,809 | 8,520 |
Free Cash Flow | -44,810 | -69,057 | -72,806 | -65,344 |
Cash | 64,025 | 106,229 | 190,304 | 174,579 |
Basic Shares | 84,580 | 83,106 | 82,526 | 82,043 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $62,043 | $153,731 | $67,772 | $61,880 |
Gross Profit | 54,825 | 146,915 | 59,484 | 52,107 |
EBITDA | -180,453 | -67,915 | -105,070 | -97,557 |
EBIT | -187,671 | -74,731 | -113,358 | -102,401 |
Net Income | -227,461 | -106,793 | -119,204 | -105,538 |
Net Change In Cash | 62,043 | 153,731 | 67,772 | 61,880 |
Cost of Revenue | -175,738 | |||
Free Cash Flow | -194,638 | -115,931 | -4,309 | -97,002 |
Cash | 190,304 | 69,268 | 47,254 | 30,414 |
Basic Shares | 76,829 | 60,163 | 50,739 | 46,119 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.14 |
2025-03-31 | -$0.91 |
2024-12-31 | -$0.63 |
